Month: April 2021

RT @RetinalPhys: Retinal OCT Biomarkers for Clinicians and Clinical Researchers:…

[ad_1] RT @RetinalPhys: Retinal OCT Biomarkers for Clinicians and Clinical Researchers: Recent studies may yield meaningful prognostic and treatme… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

OIS Podcast Episode #270: KOLs Speak Out on the Future of Gene Therapy via @You…

[ad_1] OIS Podcast Episode #270: KOLs Speak Out on the Future of Gene Therapy https://t.co/nXMnR91Btg via @YouTube [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Gene Therapy for Retinal Disease via @YouTube…

[ad_1]
Gene Therapy for Retinal Disease https://t.co/CDezBt3HxD via @YouTube
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Given recent clinical trial results in geographic atrophy/dry AMD, there has bee…

[ad_1] Given recent clinical trial results in geographic atrophy/dry AMD, there has been great interest in our review of complement inhibition as a therapeutic strategy in retinal disorders #retina #eye #macula #AMD #clinicaltrials https://t.co/z4YaBgcE1n [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinalPhys: Accessing the suprachoroidal space can bypass the ILM barrier a…

[ad_1] RT @RetinalPhys: Accessing the suprachoroidal space can bypass the ILM barrier and enhance delivery of drug to the retina, RPE, and choroid… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Interesting…The potential benefits of this approach have been noted across mul…

[ad_1]
Interesting…The potential benefits of this approach have been noted across multiple species…
Efficacy and safety of suprachoroidal triamcinolone injection in horses with poorly responsive equine recurrent uveitis https://t.co/ebK5fdMGew
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published…With ~50% patients not requiring additional treatment for 9 mon…

[ad_1] Just published…With ~50% patients not requiring additional treatment for 9 months after the last CLS-TA treatment, demonstrates the potential for durability with the suprachoroidal platform & small molecule suspensions such as CLS-TA. #retina #eyes https://t.co/JRiSW8r5ht [ad_2] Source by Thomas Ciulla, MD, MBA Return to 

Looking forward to participating in this week’s Wet AMD & DME Drug Development S…

[ad_1] Looking forward to participating in this week’s Wet AMD & DME Drug Development Summit: #eyes #ophthalmology #retina #macula #diabetes #diabeticretinopathy #AMD #maculardegeneration #drugdevelopment #healthcare #biotech #biotechnology #clinicalresearch https://t.co/z903ngBrXO [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Given recent clinical trial results, there has been great interest in our review…

[ad_1]
Given recent clinical trial results, there has been great interest in our review of this pathway for the treatment of macular degeneration and diabetic macular edema …https://t.co/OaBS7cUlXs
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Just published: OCT plays a key role in retina care & clinic…

[ad_1] RT @ThomasCiullaMD: Just published: OCT plays a key role in retina care & clinical trials, but OCT biomarkers can show limited correlation… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.